Cancer screening in Australia: future directions in melanoma, Lynch syndrome, and liver, lung and prostate cancers
Year: 2019
Type: article
Abstract: While Australia now has well-established national screening programs for breast, bowel and cervical cancers, research continues into the feasibility of developing systematic screening programs for a number of other cancers. In this paper, experts in their fields provide perspectives on the current state of play and future directions for screening and surveillance for melanoma, Lynch syndrome, and liver, lung and prostate cancers in Australia. Although the evidence does not support population screening, there may be opportunities to prevent thousands of deaths through systematic approaches to the early detection of lung cancer and melanoma, testing for Lynch syndrome, and organised surveillance for hepatocellular carcinoma among individuals at high risk - guided by targeted research. The paper also looks at what impact new prostate specific antigen testing guidelines are having on screening for prostate cancer.
DOI: 10.17061/phrp2921910
Institutions: The University of Sydney, Cancer Council NSW, The University of Queensland, Prince Charles Hospital, Queen Mary University of London, Melanoma Institute Australia, The University of Melbourne, Peter MacCallum Cancer Centre, UNSW Sydney, Prince of Wales Hospital, The Royal Melbourne Hospital, St Vincent's Hospital Sydney, The University of Western Australia, Sax Institute
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W2966625709